Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. results of a prospective randomized trial.

Núñez-Moral M, Sánchez-Álvarez E, González-Díaz I, Peláez-Requejo B, Fernández-Viña A, Quintana-Fernández A, Rodríguez-Suárez C.

Perit Dial Int. 2014 May;34(3):271-7. doi: 10.3747/pdi.2012.00109.

2.

Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.

Pommer W, Brauner M, Westphale HJ, Brunkhorst R, Krämer R, Bundschu D, Höffken B, Steinhauer HB, Schümann E, Lüttgen FM, Schillinger-Pokorny E, Schaefer F, Wende R, Offner G, Näther S, Osten B, Zimmering M, Ehrich JH, Kehn M, Mansmann U, Grosse-Siestrup C.

Am J Kidney Dis. 1998 Nov;32(5):752-60.

PMID:
9820444
3.

The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.

Johnson DW, Clark C, Isbel NM, Hawley CM, Beller E, Cass A, de Zoysa J, McTaggart S, Playford G, Rosser B, Thompson C, Snelling P; HONEYPOT Study Group..

Perit Dial Int. 2009 May-Jun;29(3):303-9.

4.

Ofloxacin solution for persistent exit-site and tunnel infection in peritoneal dialysis.

Lew SQ, Gruia A.

Perit Dial Int. 2013 Jan-Feb;33(1):101-2. doi: 10.3747/pdi.2012.00070. No abstract available.

5.
6.

Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.

Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B.

J Am Soc Nephrol. 2005 Feb;16(2):539-45.

7.
8.

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

van Esch S, Krediet RT, Struijk DG.

Perit Dial Int. 2014 Mar-Apr;34(2):162-70. doi: 10.3747/pdi.2013.00275.

9.

Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.

Kopriva-Altfahrt G, König P, Mündle M, Prischl F, Roob JM, Wiesholzer M, Vychytil A; Austrian Study Group for Prevention of Peritoneal Catheter-Associated Infections., Arneitz K, Karner A, Artes R, Wolf E, Auinger M, Pawlak A, Fraberger J, Hofbauer S, Galvan G, Salmhofer H, Pichler B, Wazel M, Gruber M, Thonhofer A, Hager A, Malajner S, Heiss S, Braunsteiner T, Zweiffler M, König P, Rudnicki M, Kogler R, Kohlhauser D, Wiesinger T, Kopriva-Altfahrt G, Moser E, Kotanko P, Loibner H, Nitz H, Miska HJ, Wenzel R, Wölfer M, Mündle M, Breuss H, Hölzl B, Prischi F, Schmekal B, Riener EM, Roob JM, Wonisch W, Vikydal R, Vychytil A, Frank B, Wieser C, Wiesholzer M, Pokorny K.

Perit Dial Int. 2009 May-Jun;29(3):330-9.

10.

Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.

Uttley L, Vardhan A, Mahajan S, Smart B, Hutchison A, Gokal R.

J Nephrol. 2004 Mar-Apr;17(2):242-5.

PMID:
15293524
11.

The comparison of exit-site care with normal saline and povidone-iodine in preventing exit-site infection and peritonitis in children on chronic peritoneal dialysis treatment.

Yavascan O, Anil M, Kara OD, Bal A, Akcan N, Senturk S, Unturk S, Aksu N.

Saudi J Kidney Dis Transpl. 2011 Sep;22(5):931-4.

12.

Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.

Thodis E, Passadakis P, Ossareh S, Panagoutsos S, Vargemezis V, Oreopoulos DG.

Int J Artif Organs. 2003 Aug;26(8):698-714. Review.

PMID:
14521167
13.

The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.

Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V.

Adv Perit Dial. 2000;16:257-61.

PMID:
11045306
14.

Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.

Rodríguez-Carmona A, Pérez-Fontán M, López-Muñiz A, Ferreiro-Hermida T, García-Falcón T.

Perit Dial Int. 2014 Sep-Oct;34(6):618-26. doi: 10.3747/pdi.2012.00185.

15.

Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.

Al-Hwiesh AK, Abdul-Rahman IS, Al-Muhanna FA, Al-Sulaiman MH, Al-Jondebi MS, Divino-Filho JC.

Int J Artif Organs. 2013 Jul;36(7):473-83. doi: 10.5301/ijao.5000207.

PMID:
23897229
16.

[Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].

Kopriva-Altfahrt G, Moser E, Prokschi A, Kraus B, Kovarik J.

Wien Klin Wochenschr. 2005;117 Suppl 6:73-82. German.

PMID:
16437337
17.

Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.

Mahajan S, Tiwari SC, Kalra V, Bhowmik DM, Agarwal SK, Dash SC, Kumar P.

Perit Dial Int. 2005 Sep-Oct;25(5):473-7.

18.
19.

Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?

Koc Y, Unsal A, Basturk T, Sakaci T, Ahbap-Dal E, Sinangil-Arar A, Kose-Budak S, Kayabasi H.

Nefrologia. 2012 May 14;32(3):335-42. doi: 10.3265/Nefrologia.pre2012.Jan.11143.

20.

The risk of peritonitis after an exit site infection: a time-matched, case-control study.

Lloyd A, Tangri N, Shafer LA, Rigatto C, Perl J, Komenda P, Sood MM.

Nephrol Dial Transplant. 2013 Jul;28(7):1915-21. doi: 10.1093/ndt/gft002.

Items per page

Supplemental Content

Support Center